There is evidence that QSM susceptibility in the temporal lobe is associated with tau deposition measured using positron emission tomography (PET) across the AD continuum (including cognitively unimpaired and impaired individuals) (Spotorno et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.